NYU Langone Health | Strategic Alliance Partners

Dr David Hudesman, Dr Jordan Axelrad, and Dr Jose Scher discuss strategies for managing coexisting inflammatory bowel disease and psoriatic arthritis and highlight the importance of a multidisciplinary approach to providing comprehensive care.

The approval of risankizumab represents the first ever IL-23 approved by the FDA for IBD.

"The best test is the 1 that gets done," Williams said.

NYU Langone Health has been recognized as No. 1 in quality and safety for inpatient and ambulatory care by Vizient, Inc. On Wednesday, September 21, 2022.

Dr. David Hudesman expects drug developers to continue to target biologics for the treatment of IBD.

Machine learning algorithms successfully predicted visual and anatomic outcomes and dosing frequency in patients with macular edema secondary to CRVO.

Event rates were inversely proportional to kidney function in patients with chronic coronary disease.

Once a day readings over a year would detect 98.3% of the first Afib >24 hour episodes, while the probability of ≥1 false positive reading would be 98%.

Dr. Modi discusses the pending approval of faricimab for nAMD, DME treatment and highlights important observations from phase 3 data.

The first iteration of Crisis Point addresses the obesity crisis in the United States and beyond, with expert interviews and discussion.

Episode 4 of Crisis Point asks the question you've been waiting for, "What is blueprint to resolving the obesity crisis?"

Episode 3 of Crisis Point examines the regional differences in obesity, from issues with nutrition and food insecurity to the use of the phrase "food desert".

Episode 2 of HCPLive Crisis Point tackles the clinical aspects and potential burdens clinicians face in the pursuit of obesity care.

HCPLive Crisis Point takes an in-depth look at the obesity crisis, beginning with the process of medical diagnosis and who is impacted the most by the disease.

Esophageal cancer has a low survival rate largely due to advanced stage diagnosis.

Missed diagnosis resulted in delays in initiation of therapy and hospital re-admissions.

Individuals diagnosed with mood or anxiety disorders were not linked to higher COVID-19 mortality.

National Health Center Week kicks off on August 9.

Psilocybin, which is commonly found in psychedelic mushrooms, is linked with enduring antianxiety and antidepressant effects.

Arjun Masurkar, MD, PhD, discusses some of the issues with Alzheimer disease clinical trials.

Arjun Masurkar, MD, PhD, discusses how genetic testing could usher in a new wave of diagnostics for Alzheimer disease.

Lenard Adler, MD, talks about some of the advances in recent years in screening for ADHD in adults and adolescents.

A discussion on why heart failure rates have climbed over the past decade while research indicates rates of cardiovascular disease, as a whole, have begun to decline.

How women's health burdens touch genetics, psychiatry, cardiology, and whether physicians are equipped to manage it all.

Discussing the key differences in the results of ISCHEMIA and ISCHEMIA-CKD, which examined whether the use of invasive or conservative strategies was more effective for patients with ischemic heart disease.

In months, the US may have its first marketed peanut immunotherapies. How will pediatric patient management change?

Discussing why initiatives and policy changes in the fight against obesity and diabetes have been perceived as less successful than those against smoking and educating on cardiovascular diseases.

How PTSD care can be, and should be, individualized for particular patient needs.

Evaluating the impact of DAPA-HF and other recent data that have changed the way cardiologists view the potential uses of SGLT2 inhibitors in patients with or without diabetes.

Discussing how new information released in 2019 has impacted the way cardiologists view aspirin use for primary and secondary prevention of cardiovascular events.